Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
18 Cards in this Set
- Front
- Back
Rapid acting insulin (3)
|
lispro, aspart, glulisine
|
|
Long acting insulins (2)
|
detemir, glargine
|
|
sulfonylureas (3)
|
glyburide, glipizide, glimepiride
|
|
Glitinides (2)
|
insulin secretagoge. Repaglinide, nateglinide. No sulfur in structure thus can be given to sulfonylurea allergies.
|
|
Biguanide (1)
|
metformin. decreases endogenous glucose production.
|
|
tolbutamide
|
sulfonylurea. 1st gen, rarely used except in older diabetics because of short half-life.
|
|
-amide
|
sulfonylurea (1st gen). -ide = 2nd gen sulfonyurea.
|
|
MOA of thiazolidinediones
|
regulates gene expressino by binding to PPAR-gamma.
|
|
rosiglitazone
|
thiazolidinedione
|
|
pioglitazone
|
thiazolidinedione
|
|
acarbose
|
alpha-glucosidasde inhibitor. reduces conversion of starch and disaccharides to monosaccharides, prevents post-prandial hyperglycemia.
|
|
miglitol
|
alpha-glucosidasde inhibitor. reduces conversion of starch and disaccharides to monosaccharides, prevents post-prandial hyperglycemia.
|
|
exentatide
|
GLP-1 analogue. Reduces post-meal glucose excursions: increases glucose-mediated insulin release, lowers glucagon levels, slows gastric emptying, decreases appetite.
|
|
sitagliptin
|
DPP-4 inhibitor (blocks degradation of GLP-1). thus, GLP-1 analogue. Reduces post-meal glucose excursions: increases glucose-mediated insulin release, lowers glucagon levels, slows gastric emptying, decreases appetite.
|
|
pramlintide
|
amylin analogue. Reduces post-meal glucose excursions: , lowers glucagon levels, slows gastric emptying, decreases appetite.
|
|
what drug class may prevent diabetes II?
|
Thiazoladinediones. (pioglitazone, rosiglitazone)
|
|
-glitazone
|
Thiazoladinediones.
|
|
Which drug class reduces hepatic glucose elevation through activation of AMP-activated protein kinase (AMPK)?
|
Biguanides (metformin).
|